David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 36,000 shares at $32.66 ($1.2M) on 2021-10-07, disclosed to the SEC on 2021-10-08.
Open-market sale of $1.2M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.66 | 15,471 | $505K | 43.1% |
| 2 | $32.66 | 15,471 | $505K | 43.1% |
| 3 | $32.05 | 2,529 | $81K | 6.9% |
| 4 | $32.05 | 2,529 | $81K | 6.9% |
| Total | $32.57 avg | 36,000 | $1.2M | 100% |
| Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |
| PHAT | SELL | 2021-04-07 | $2.9M | — | Filing → |